Asymmetry Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-24,575
Closed -$2.7M 37
2018
Q2
$2.7M Sell
24,575
-7,654
-24% -$797K 2.66% 14
2018
Q1
$3.23M Sell
32,229
-31,381
-49% -$3.21M 4.04% 8
2017
Q4
$6.26M Buy
63,610
+25,390
+66% +$2.41M 8.5% 2
2017
Q3
$3.58M Buy
38,220
+7,466
+24% +$793K 4.15% 8
2017
Q2
$3.42M Sell
30,754
-6,631
-18% -$701K 4.05% 13
2017
Q1
$3.67M Buy
37,385
+7,900
+27% +$753K 5.12% 11
2016
Q4
$2.71M Buy
29,485
+24,785
+527% +$2.14M 5.04% 9
2016
Q3
$398K Sell
4,700
-30,143
-87% -$2.53M 0.69% 19
2016
Q2
$2.84M Sell
34,843
-28,752
-45% -$2.19M 5.2% 8
2016
Q1
$4.54M Sell
63,595
-29,850
-32% -$2M 11.85% 3
2015
Q4
$6.65M Buy
93,445
+32,925
+54% +$2.21M 10.05% 3
2015
Q3
$3.72M Buy
+60,520
New +$4.23M 8.29% 3

Other funds holding DGX

Asymmetry Capital Management's DGX Position: Q3 2018 in Review

Asymmetry Capital Management sold out of Quest Diagnostics (DGX) in Q3 2018, closing a stake of 24,575 shares — an estimated $2.7M sold.

Asymmetry Capital Management first reported a position in DGX in Q3 2015 and held it in 12 quarters. The position peaked at $6.65M in Q4 2015. 673 funds tracked by Wall St. Rank hold DGX as of Q3 2018.

  • Asymmetry Capital Management reported no remaining Quest Diagnostics position as of Q3 2018 after selling out during the quarter.
  • Asymmetry Capital Management sold 24,575 Quest Diagnostics shares in Q3 2018, an estimated $2.7M.
  • Asymmetry Capital Management first reported a position in Quest Diagnostics in Q3 2015 and held it in 12 quarters.
  • Asymmetry Capital Management's Quest Diagnostics position peaked at $6.65M in Q4 2015.
  • 673 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.

Based on Asymmetry Capital Management's 13F filing for Q3 2018, filed 8 Nov 2018.